Dysprosium (Dy) |
61.2 B2O3–8.8 Li2O–61.2 Dy2O3 (wt.%) |
Drug delivery and radiation therapy |
Melt-quenching |
Microspheres with a particles size range from 45 to 150 µm |
[133] |
50 SiO2–30 CaO–10 Fe2O3–10 Dy2O3 (mol%) |
Radiotherapy and hyperthermia |
Sol–gel |
Porous glass powder after thermal treatment at 500 and 800 °C |
[135] |
Europium (Eu) |
70 SiO2–20 CaO–5 P2O5 with 5 Eu2O3 (or Tb2O3) (mol%) |
Bone regeneration and drug delivery |
Sol–gel |
Mesoporous nanofibers with an average diameter of 100–120 nm |
[59] |
100 SiO2 with 1, 2, and 3 Eu2O3 (mol%) |
Skin and bone regeneration |
Sol–gel |
Mesoporous nanospheres with a particle size range of 280-300 nm |
[69] |
SiO2–CaO–P2O5 with 5 Eu2O3 (mol%) |
Drug delivery |
Sol–gel |
Mesoporous powder |
[58] |
60 SiO2–36 CaO–4 P2O5 with 0, 0.5, 1, and 2 Eu2O3 (mol%) |
Bone regeneration |
Sol–gel |
Mesoporous nanospheres with a particle size around 500 nm |
[57] |
80 SiO2–16 CaO–4 P2O5 with 1, 2, and 3 Eu2O3 (mol%) |
Cell imaging and bone regeneration |
Sol–gel |
Nanoparticles with a particle size range of 200–400 nm |
[60] |
80 SiO2–15 CaO–5 P2O5 with 0, 1, 2, and 5 Eu2O3 (mol%) |
Cell imaging and bone regeneration |
Sol–gel |
Mesoporous bioactive glass scaffolds with a pore size range of 300–500 µm |
[70] |
Gadolinium (Gd), Ytterbium (Yb) and Thulium (Tm) |
47.28 SiO2–31.39 Na2O–15.33 CaO–6 P2O5 with 2.5 Gd2O3 or Yb2O (wt.%) |
Tissue engineering |
Melt-quenching |
Glass powder with a particle size of less than 125 µm |
[85] |
SiO2–CaO–Gd2O3 with the Ca:Gd molar ratios 3:1 and 5:1 |
Bone regeneration |
Sol–gel |
Combination of mesoporous calcium silicate scaffold with chitosan using lyophilization technique |
[90] |
84 SiO2–12 CaO–4 P2O5 with the Ca:Gd molar ration 3:1, 5:1, and 7:1 |
Bone regeneration |
Sol–gel |
Microsphere powder with a particle size around 300 nm + BG scaffold using lyophilization technique |
[89] |
47.28 SiO2–31.39 NaO2–15.33 CaO–6 P2O5 with 2.5 Gd2O3 or 2.5 Yb2O3 or 0.5 Fe2O3 (wt.%) |
Biomedical applications |
Melt-quenching |
Glass powder with a particle size of less than 75 µm |
[84] |
63 SiO2–37 CaO with 0.15, 0.3 and 0.5 Tm2O3 and 0, 1, 2, 3 and 4 Yb2O3 (mol.%) |
Regenerative medicine or drug delivery |
Sol–gel |
Glass powder with a particle size range of 80–120 nm |
[91] |
Holmium (Ho) |
58 SiO 2–33 CaO–9 P2O5 with 1.25, 2.5 and 5 Ho2O3 (wt.%) |
Brachytherapy |
Sol–gel |
Glass powder |
[78] |
58 SiO2–33 CaO–9 P2O5 with 1.25, 2.5, 3.75, and 5 Ho2O3 (wt.%) |
Brachytherapy |
Sol–gel |
Glass powder incorporated into the Poloxamer 407 hydrogel (20 wt.%) |
[79] |
Lanthanum (La) |
67 SiO2–5 Na2O–24 CaO–4 P2O5 with 5 La2O3 (or CuO) (mol%) |
Tissue engineering |
Sol–gel |
Glass powder with a particle size of less than 63 µm and BG scaffolds with macropores in the range of 300–500 µm using the robocasting technique |
[124] |
64.4 SiO2–2.48 Na2O–21.53 CaO–4.55 P2O5 with 0, 1, 3 and 5 wt.% La2O3 (or/and CuO) |
Tissue engineering |
Sol–gel |
Glass powder with a particle size range of 3.5–4.6 µm |
[123] |
25 Na2O–25 CaO–50 P2O5 with 5 and 10 La2O3 (mol%) |
Drug delivery |
Sol–gel |
Mesoporous nanoparticles with a particle size range of 25–100 nm |
[118] |
58 SiO2–38 CaO–4 P2O5–1 La2O3 (wt.%) |
Bone regeneration |
Sol–gel |
Glass powder |
[125] |
20 Na2O–14 CaO–66 P2O5 with 0, 0.1, 0.3, 0.7 and 1 La2O3 (mol%) |
Tissue engineering |
Melt-quenching |
Glass powder with a particle size range of 106–180 µm |
[116] |
Samarium (Sm) |
45 SiO2–24.5 Na2O–24.5 CaO–6 P2O5 with 0, 1, 2, 3, and 4 Sm2O3 (wt.%) |
Bone regeneration |
Melt-quenching |
Glass powder |
[97] |
46.1 SiO2–24.4 Na2O–26.9 CaO–6 P2O5 with 0, 0.2, and 2 Sm2O3 (wt.%) |
Tissue engineering |
Melt-quenching |
Glass powder with a particle size of around 100 µm |
[93] |
SiO2–CaO–P2O5 with 0, 0.5, and 1 Sm2O3 (mol%) |
Bone cancer |
Sol–gel |
Combination of mesoporous bioactive glass with alginate powder with a particle size of around 1200 µm |
[98] |
45.6 SiO2–24.4 Na2O–26.9 CaO–2.6 P2O5 with 0.5 Sm2O3 (mol%) |
Biomedical applications |
Melt-quenching |
Glass fiber with a diameter of 100 µm from the glass melt |
[96] |
10 Na2O–15 CaO–65 P2O5–15 CaF2 with 0, 0.5, 1, and 2 Sm2O3 (mol%) |
Bone regeneration |
Melt-quenching |
Mixing of 2.5% glass powder with 97.5% of hydroxyapatite powder (wt.%) |
[99] |
Terbium (Tb) and Erbium (Er) |
79.5 SiO2–15 CaO–5 P2O5 with 0.5 and 1 Tb2O3 (mol%) |
Bone regeneration |
Sol–gel |
Mesoporous nanospheres with a particle size range of 100–200 nm |
[130] |
53 SiO2–6 Na2O–20 CaO–4 P2O5–12 K2O–5 MgO with 1, 3, 5 Tb2O3 or 1, 3, 5 Er2O3 or 0.5, 1.5, and 2.5 with co-dopingTb2O3 and Er2O3 (wt.%) |
Bioimaging |
Sol–gel |
Glass powder with a particle size range of 1.45–3.57 µm |
[132] |
30 Na2O–25 CaO–45P2O5 with 0, 1, 3, and 5 Y2O3 (mol%) |
Radiotherapy |
Melt-quenching |
Glass powder |
[113] |
62.35 SiO2–15.85 Na2O–(20.80–x) CaO–1.0 P2O5 with x = 0 and 4.68 Y2O3 (mol%) |
Radiotherapy |
Melt-quenching |
Glass powder |
[112] |
58 SiO2–33 CaO–9 P2O5 with 10 Y2O3 (wt.%) |
Radiotherapy |
Sol–gel |
Glass powder with an average particle size of 1 µm |
[105] |
Yttrium (Y) |
6 Na2O–20 CaO–4 P2O5–12 K2O–5 MgO–52 B2O3–1 Y2O3 (wt.%) |
Tissue engineering |
Melt-quenching |
Glass powder with a particle size range of 100–300 µm |
[114] |